Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Gujarat recipients gung-ho on COVID-19 vaccine
The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round
COVID-19 vaccine update: People above 45 eligible for jabs from April 1
Ministry of Home Affairs releases updated guidelines for COVID-19 control
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Coronavirus update: AstraZeneca halts global vaccine trials
COVID-19 has affected 19 sectors in India that were not under stress earlier, with a total Rs 15.5 lakh crore outstanding debt; retail and …
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic
The take-home message is that variants will emerge, and we need to closely monitor their spread
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached